Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a german multicenter trial

Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a german multicenter trial

<p>Abstract</p> <p>Gastrointestinal stromal tumors (GIST) are mesenchymal tumors that in the past were classified as leiomyosarcomas or leiomyomas not responding to standard sarcoma chemotherapy. In several phase I and II trials the efficacy and safety of imatinib was shown before...

Full description

Bibliographic Details
Main Authors:	Schlemmer M, Bauer S, Schütte R, Hartmann JT, Bokemeyer C, Hosius C, Reichardt P
Format:	Article
Language:	English
Published:	BMC 2011-05-01
Series:	European Journal of Medical Research
Online Access:	http://www.eurjmedres.com/content/16/5/206

Similar Items

Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate
by: Omar S Din, et al.
Published: (2008-03-01)

A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor
by: Maria A. Pantaleo, et al.
Published: (2022-05-01)

Heterogeneity of Metabolic Vulnerability in Imatinib-Resistant Gastrointestinal Stromal Tumor
by: Wen-Kuan Huang, et al.
Published: (2020-05-01)

Identification of Novel Imatinib-Resistant Genes in Gastrointestinal Stromal Tumors
by: Lei Cao, et al.
Published: (2022-05-01)

Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib
by: Richard Quek, et al.
Published: (2010-02-01)

Imatinib-induced podocytopathies in a patient with gastrointestinal stromal tumor
by: Gang Wang, et al.
Published: (2021-01-01)

ZNF-mediated resistance to imatinib mesylate in gastrointestinal stromal tumor.
by: Lori Rink, et al.
Published: (2013-01-01)

Sigmoid Sinus Thrombosis Followed by Splenic Infarction Due to Imatinib Therapy in a Patient with Gastrointestinal Stromal Tumor; Hematological Side Effects of Imatinib
by: Hatice YILMAZ, et al.
Published: (2021-03-01)

MDCT appearance of gastrointestinal stromal tumors after therapy with imatinib mesylate.
by: Warakaulle, DR, et al.
Published: (2006)

Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors
by: S. V. Boichuk, et al.
Published: (2015-06-01)

Advances in the research of the mechanism of secondary resistance to imatinib in gastrointestinal stromal tumors
by: Xiangchen Hu, et al.
Published: (2022-09-01)

Secondary resistance to imatinib in gastrointestinal stromal tumors mediated by EPHB2
by: LIU Zong-hang, et al.
Published: (2022-12-01)

Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy
by: Gibbons Joseph, et al.
Published: (2009-03-01)

Recent Advancements in the Treatment of Rectal Gastrointestinal Stromal Tumor: In Era of Imatinib
by: Qu H, et al.
Published: (2022-03-01)

Benefit of Continuation of Low-Dose Imatinib for Gastrointestinal Stromal Tumors despite Adverse Events with Regular-Dose Imatinib
by: Ryo Katsumata, et al.
Published: (2023-02-01)

Emerging Targeted Therapeutic Strategies to Overcome Imatinib Resistance of Gastrointestinal Stromal Tumors
by: Maria Teresa Masucci, et al.
Published: (2023-03-01)

Imatinib use for gastrointestinal stromal tumors among older patients in Japan and Taiwan
by: Yuichi Ichinose, et al.
Published: (2022-12-01)

Rapidly progressive dyspnea in gastrointestinal stromal tumor (GIST) with imatinib cardiac toxicity
by: Adnan Asif Parvez Ghias, et al.
Published: (2018-03-01)

Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor
by: Chaoyong Shen, et al.
Published: (2014-11-01)

Imatinib Mesylate: Past Successes and Future Challenges in the Treatment of Gastrointestinal Stromal Tumors
by: Doran Ksienski
Published: (2011-01-01)

A rectal gastrointestinal stromal tumor—a plea for neoadjuvant imatinib and TAMIS
by: Jagan Balu, et al.
Published: (2020-01-01)

Hepatitis B Virus Reactivation in Gastrointestinal Stromal Tumor Patients Treated With Imatinib
by: Tianxiang Lei, et al.
Published: (2021-01-01)

Imatinib Mesylate: Past Successes and Future Challenges in the Treatment of Gastrointestinal Stromal Tumors
by: Doran Ksienski
Published: (2011-11-01)

Spontaneous hemoperitoneum in recurrent jejunal gastrointestinal stromal tumor after imatinib therapy
by: Tzu-Chieh Yin
Published: (2013-07-01)

Current and emerging strategies for the management of imatinib-refractory advanced gastrointestinal stromal tumors
by: Damien Kee, et al.
Published: (2012-09-01)

NEOADJUVANT IMATINIB AND RADIOTHERAPY IN GASTROINTESTINAL STROMAL TUMOR OF THE RECTUM: A CASE REPORT
by: Rocco Luca Emanuele Liardo
Published: (2015-04-01)

Imatinib-Resistant Gastrointestinal Stromal Tumor Presenting as a Large Abdominal Mass
by: Asim Haider, et al.
Published: (2021-08-01)

Preservation of Organ Function in Locally Advanced Non-Metastatic Gastrointestinal Stromal Tumors (GIST) of the Stomach by Neoadjuvant Imatinib Therapy
by: Nikolaos Vassos, et al.
Published: (2021-02-01)

Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registry
by: Call Jerry, et al.
Published: (2012-03-01)

Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment.
by: Michaela Angelika Ihle, et al.
Published: (2018-01-01)

Sarcomas del estroma gastrointestinal tratados con Imatinib®: presentación de 2 casos Gastrointestinal stromal tumors treated with Imatinib®: report of 2 cases
by: Mayté Lima, et al.
Published: (2006-06-01)

Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors
by: Claudia Angela Maria Fulgenzi, et al.
Published: (2022-06-01)

Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: is it worthwhile?
by: Tielen Ronald, et al.
Published: (2012-06-01)

Gastrointestinal stromal tumor of the rectum treated with neoadjuvant Imatinib followed by transanal endoscopic microsurgery
by: Caio Sergio Rizkallah NAHAS, et al.
Published: (2015-01-01)

Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor
by: Hwang Jun-Eul, et al.
Published: (2010-08-01)

Imatinib-induced hepatitis treated by corticosteroids in a patient with metastatic gastrointestinal stromal tumor
by: Min Kyu Kang, et al.
Published: (2019-05-01)

Safety of Regular-Dose Imatinib Therapy in Patients with Gastrointestinal Stromal Tumors Undergoing Dialysis
by: Ryota Niikura, et al.
Published: (2016-05-01)

Deciphering the tumor immune microenvironment of imatinib-resistance in advanced gastrointestinal stromal tumors at single-cell resolution
by: Xuechao Liu, et al.
Published: (2024-03-01)

Complete response to imatinib treatment in jejunal leiomyosarcoma subsequently developing gastrointestinal stromal tumor and desmoid tumor
by: Yuji Kurihara, et al.
Published: (2014-01-01)

Imatinib as adjuvant treatment following resection of KIT-positive gastrointestinal stromal tumours
by: J Dretzke, et al.
Published: (2010-10-01)